199 related articles for article (PubMed ID: 20581132)
1. Stroke thrombolysis in England, Wales and Northern Ireland: how much do we do and how much do we need?
Rudd AG; Hoffman A; Grant R; Campbell JT; Lowe D;
J Neurol Neurosurg Psychiatry; 2011 Jan; 82(1):14-9. PubMed ID: 20581132
[TBL] [Abstract][Full Text] [Related]
2. Time trends in systemic thrombolysis in a large hospital-based stroke registry.
Singer OC; Hamann GF; Misselwitz B; Steinmetz H; Foerch C;
Cerebrovasc Dis; 2012; 33(4):316-21. PubMed ID: 22343969
[TBL] [Abstract][Full Text] [Related]
3. [Estimation of patient eligibility for thrombolysis in acute ischaemic stroke based on a hospital stroke registry in Warsaw].
Kobayashi A; Sarzyńska-Długosz I; Niewada M; Skowrońska M; Członkowska A
Neurol Neurochir Pol; 2006; 40(5):369-75. PubMed ID: 17103349
[TBL] [Abstract][Full Text] [Related]
4. Stroke thrombolysis in England: an age stratified analysis of practice and outcome.
Bray BD; Campbell J; Hoffman A; Tyrrell PJ; Wolfe CD; Rudd AG
Age Ageing; 2013 Mar; 42(2):240-5. PubMed ID: 23174425
[TBL] [Abstract][Full Text] [Related]
5. [Thrombolytic therapy in patients with acute brain infarction: favorable preliminary results in Maastricht].
Boiten J; Wilmink JT; Lodder J; Troost J
Ned Tijdschr Geneeskd; 2000 May; 144(22):1062-9. PubMed ID: 10850109
[TBL] [Abstract][Full Text] [Related]
6. Access to stroke care in England, Wales and Northern Ireland: the effect of age, gender and weekend admission.
Rudd AG; Hoffman A; Down C; Pearson M; Lowe D
Age Ageing; 2007 May; 36(3):247-55. PubMed ID: 17360793
[TBL] [Abstract][Full Text] [Related]
7. Estimating the number of stroke patients eligible for thrombolytic treatment if delay could be avoided.
Boode B; Welzen V; Franke C; van Oostenbrugge R
Cerebrovasc Dis; 2007; 23(4):294-8. PubMed ID: 17199087
[TBL] [Abstract][Full Text] [Related]
8. Intravenous thrombolysis for acute ischemic stroke in the 3- to 4·5-hour window--the Malabar experience.
Salam KA; Ummer K; Pradeep Kumar VG; Noone ML
Int J Stroke; 2014 Jun; 9(4):426-8. PubMed ID: 23981667
[TBL] [Abstract][Full Text] [Related]
9. Acute stroke management in the elderly.
Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
[TBL] [Abstract][Full Text] [Related]
10. [Effective acute stroke treatment beyond approval limitations: intravenous thrombolysis within an extended time window (3-6 h) and in old patients (aged 80 or older)].
Thomalla G; Köhrmann M; Röther J; Schellinger PD
Fortschr Neurol Psychiatr; 2007 Jun; 75(6):343-50. PubMed ID: 17366377
[TBL] [Abstract][Full Text] [Related]
11. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
[TBL] [Abstract][Full Text] [Related]
12. Relationship between hospital volume and early outcomes in acute ischemic stroke patients treated with recombinant tissue plasminogen activator.
Wada T; Yasunaga H; Inokuchi R; Horiguchi H; Fushimi K; Matsubara T; Nakajima S; Yahagi N
Int J Stroke; 2015 Jan; 10(1):73-8. PubMed ID: 25043743
[TBL] [Abstract][Full Text] [Related]
13. Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: an audit of current practice and clinical outcomes.
Williams JM; Navin TJ; Jude MR; Levi CR
Aust J Rural Health; 2013 Aug; 21(4):203-7. PubMed ID: 24033520
[TBL] [Abstract][Full Text] [Related]
14. United States trends in thrombolysis for older adults with acute ischemic stroke.
George BP; Asemota AO; Dorsey ER; Haider AH; Smart BJ; Urrutia VC; Schneider EB
Clin Neurol Neurosurg; 2015 Dec; 139():16-23. PubMed ID: 26363362
[TBL] [Abstract][Full Text] [Related]
15. Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time.
Minnerup J; Wersching H; Ringelstein EB; Schilling M; Schäbitz WR; Wellmann J; Berger K
Stroke; 2011 Oct; 42(10):2838-43. PubMed ID: 21852612
[TBL] [Abstract][Full Text] [Related]
16. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
[TBL] [Abstract][Full Text] [Related]
17. Thrombolysis despite recent stroke: a case series.
Alhazzaa M; Sharma M; Blacquiere D; Stotts G; Hogan M; Dowlatshahi D
Stroke; 2013 Jun; 44(6):1736-8. PubMed ID: 23549131
[TBL] [Abstract][Full Text] [Related]
18. Intravenous thrombolysis for acute ischaemic stroke: preliminary experience with recombinant tissue plasminogen activator in the UK.
Walters MR; Muir KW; Harbison J; Lees KR; Ford GA
Cerebrovasc Dis; 2005; 20(6):438-42. PubMed ID: 16230848
[TBL] [Abstract][Full Text] [Related]
19. A case-controlled comparison of thrombolysis outcomes between wake-up and known time of onset ischemic stroke patients.
Manawadu D; Bodla S; Jarosz J; Keep J; Kalra L
Stroke; 2013 Aug; 44(8):2226-31. PubMed ID: 23723307
[TBL] [Abstract][Full Text] [Related]
20. Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR.
Ahmed N; Wahlgren N; Grond M; Hennerici M; Lees KR; Mikulik R; Parsons M; Roine RO; Toni D; Ringleb P;
Lancet Neurol; 2010 Sep; 9(9):866-74. PubMed ID: 20667790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
